GSR and MEI Pharma Announce Landmark $100M PIPE Deal, Institutionalizing Litecoin as Treasury Asset; LTC Creator Charlie Lee Joins Board to Drive Crypto Adoption in Public Markets

MEI Pharma, a Nasdaq-listed oncology-focused biotech company, has entered into a $100 million private investment in public equity (PIPE) to fund a new corporate treasury strategy centered on Litecoin (LTC). The PIPE, led by digital asset firm GSR and capital markets group Titan Partners, involves the sale of approximately 29.2 million shares of common stock (or pre-funded warrants) at $3.42 per share, with closing expected around July 22, 2025, subject to customary conditions. Under the terms of the deal, MEI intends to deploy essentially 100% of the net proceeds to acquire LTC, making Litecoin the company’s primary treasury reserve asset and positioning MEI as the first and only publicly traded company on a U.S. national exchange to adopt Litecoin in this role. As part of the transaction, Litecoin creator Charlie Lee—also a lead investor in the PIPE—will join MEI Pharma’s board of directors upon closing, while GSR will serve as digital asset and treasury management advisor to oversee implementation of the Litecoin treasury strategy. The initiative is being developed in cooperation with the Litecoin Foundation and a syndicate of crypto-focused investment firms, and is framed by GSR as a landmark step toward institutionalizing Litecoin as a treasury asset in public markets. For the biotech sector, the deal is notable because a clinical‑stage pharmaceutical company is adopting a crypto asset as a core reserve on its balance sheet, blending high‑risk drug development with a volatile digital asset strategy; for the broader crypto market, it extends the corporate‑treasury playbook pioneered with Bitcoin into a new large‑cap cryptocurrency and creates a high‑profile test case for LTC’s role as a long-term store of value on a public company’s balance sheet.

✨ AI-generated background, compiled from web sources — not editorial content.

More coverage

• MEI Pharma announces $100M PIPE deal to add Litecoin ... - Binance (binance.com)
• MEI Pharma Acquires Litecoin, Launches $100M Institutional ... (businesswire.com)
• First Public Company Adopts Litecoin with $100M Treasury Investment (stocktitan.net)
• MEI Pharma Announces $100M Placement To Initiate Litecoin ... (stocktwits.com)
• MEI Pharma Announces $100M Placement To Initiate Litecoin ... (in.investing.com)

Explore the topic

• Institutional Adoption
• GSR
• Bitcoin Treasury
• Litecoin